Listed

Brady Corp: Form 10-Q for the period ended Jan 31, 2022

Filed with the SEC on Feb 17, 2022 and accepted by EDGAR at Feb 17, 2022, 07:19 ET.

Share

Management's discussion and analysis

As filed, 32,157 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative safety, identification and healthcare products. The WPS segment manufactures a broad range of stock and custom identification products and sells a broad range of resale products.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve the efficiency of our global operations, deliver a high level of customer service, develop and market innovative new products, and to advance our digital capabilities. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal 2022:

  • Investing in organic growth by enhancing our research and development process and utilizing customer feedback to develop innovative new products.
  • Investing in acquisitions that enhance our strategic position and accelerate long-term sales growth.
  • Providing our customers with the highest level of customer service.
  • Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.
  • Maintaining profitability through pricing mechanisms to mitigate the impacts of supply chain disruptions and inflationary pressures.
  • Driving operational excellence and executing sustainable efficiency gains within our selling, general and administrative and global operations structures including insourcing of critical products and manufacturing activities.
  • Building on our culture of diversity, equity and inclusion to increase employee engagement and enhance recruitment and retention practices.

Impact of the COVID-19 Pandemic on Our Business

The Company has experienced, and expects to continue to experience, increased freight and input material cost inflation as a result of increased global demand, government-mandated actions in response to COVID-19 and labor shortages. The Company has taken and will continue to take actions to mitigate inflation issues, but thus far has not fully offset the impact of these trends. As a result, these trends have negatively impacted the Company's gross profit margin, and we expect ongoing inflationary pressures and supply chain issues will continue to negatively impact profitability in the second half of fiscal 2022.

We believe we have the financial strength to continue to invest in organic sales growth opportunities, inorganic sales opportunities including acquisitions, sales and marketing, and research and development ("R&D"), while continuing to drive sustainable efficiencies and automation in our operations and selling, general and administrative ("SG&A") functions. At January 31, 2022, we had cash of $147.4 million, as well as a credit facility with $115.3 million available for future borrowing, which can be increased up to $315.3 million at the Company's option and subject to certain conditions, for total available liquidity of approximately $462.7 million.

We believe that our financial resources and liquidity levels including the remaining undrawn amount of the credit facility and our ability to increase that credit line as necessary are sufficient to manage the continuing impact of the COVID-19 pandemic, including the spread of variants that could result in additional government actions around the world to contain the virus or prevent further spread which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2021, for further discussion of the possible impact of the COVID-19 pandemic on our business.

Results of Operations

The comparability of the operating results for the three and six months ended January 31, 2022, to the prior year has been impacted by the following acquisitions:

Acquisitions Segment Date Completed
Magicard Holdings Limited ("Magicard") IDS May 2021
Nordic ID Oyj ("Nordic ID") IDS May 2021
The Code Corporation ("Code") IDS June 2021

A comparison of results of operating income for the three and six months ended January 31, 2022 and 2021, is as follows:

(Dollars in thousands)

Three months ended January 31, 2022 % Sales 2021 % Sales Six months ended January 31, 2022 % Sales 2021 % Sales
Net sales $318,055 $265,838 $639,530 $543,065
Gross margin 149,362 47.0% 129,522 48.7% 304,350 47.6% 264,950 48.8%
Operating expenses:
Research and development 13,965 4.4% 9,876 3.7% 27,872 4.4% 20,079 3.7%
Selling, general and administrative 92,525 29.1% 82,234 30.9% 189,271 29.6% 165,271 30.4%
Total operating expenses 106,490 33.5% 92,110 34.6% 217,143 34.0% 185,350 34.1%
Operating income $42,872 13.5% $37,412 14.1% $87,207 13.6% $79,600 14.7%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation and sales recorded from acquired companies prior to the first anniversary date of their acquisition which, for the periods reported in this Form 10-Q, includes each of Magicard, Nordic ID and Code. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended January 31, 2022, increased 19.6% to $318.1 million, compared to $265.8 million in the same period in the prior year. The increase consisted of organic sales growth of 13.1%, sales growth from acquisitions of 8.6% and a decrease from foreign currency translation of 2.1%. Organic sales grew 16.0% in the IDS segment and 5.2% in the WPS segment during the three months ended January 31, 2022, compared to the same period in the prior year.

In the first quarter of fiscal 2021, the IDS business began to recover from a decline in sales due to the impacts of the COVID-19 pandemic on a large demographic of our customers and the overall global economy, while the WPS segment realized strong organic sales growth due to increased sales of personal protective equipment and other pandemic-related products. As a result, the recovery from the COVID-19 pandemic had a significant impact on year-to-date organic sales through the second quarter of fiscal 2022, with the impact varying between the IDS and WPS businesses due to sales patterns realized during the height of the pandemic in fiscal 2021.

Net sales for the six months ended January 31, 2022, increased 17.8% to $639.5 million, compared to $543.1 million in the same period in the prior year. The increase consisted of organic sales growth of 10.0%, sales growth from acquisitions of 8.5% and a decrease from foreign currency translation of 0.7%. Organic sales increased 14.6% in the IDS segment and declined 2.0% in the WPS segment during the six months ended January 31, 2022, compared to the same period in the prior year.

Gross margin increased 15.3% to $149.4 million in the three months ended January 31, 2022, compared to $129.5 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 47.0% compared to 48.7% in the same period in the prior year. Gross margin increased 14.9% to $304.4 million for the six months ended January 31, 2022, compared to $265.0 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 47.6% compared to 48.8% in the same period in the prior year. The decrease in gross margin as a percentage of net sales was primarily due to an increase in the cost of materials, labor and freight, which was partially mitigated by our ongoing efforts to streamline manufacturing processes, drive sustainable operational efficiencies and increase prices.

R&D expenses increased 41.4% to $14.0 million and increased 38.8% to $27.9 million for the three and six months ended January 31, 2022, respectively, compared to $9.9 million and $20.1 million in the same periods in the prior year. The increase in R&D spending for both the three and six-month periods was primarily due to the acquisitions of Code and Nordic ID, as these companies operate with a greater amount of R&D spend as a percentage of net sales compared to Brady's organic business. In addition, R&D headcount increased in the IDS business. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers, materials, and the building out of a comprehensive industrial track and trace solution continue to be the primary focus of R&D expenditures for the remainder of fiscal 2022.

SG&A expenses include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other general and administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses increased 12.5% to $92.5 million in the three months ended January 31, 2022, compared to $82.2 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to 29.1% compared to 30.9% in the same period in the prior year. The increase in SG&A expenses was primarily due to the acquisitions of Code, Magicard and Nordic ID, and to a lesser extent an increase in sales and marketing personnel in the IDS business and increased personnel costs in the WPS business.

SG&A expenses increased 14.5% to $189.3 million for the six months ended January 31, 2022, compared to $165.3 million in the same period in the prior year. As a percentage of net sales, SG&A expense decreased to 29.6% from 30.4% in the same period in the prior year. The increase in SG&A expense was primarily due to the acquisitions of Code, Magicard and Nordic ID, and to a lesser extent an increase in personnel costs and advertising costs in both the IDS and WPS businesses. The decrease in SG&A expense as a percentage of sales for the three and six month periods ended January 31, 2022, was primarily due to ongoing efficiency activities throughout SG&A.

Operating income increased 14.6% to $42.9 million and increased 9.6% to $87.2 million for the three and six months ended January 31, 2022, respectively, compared to $37.4 million and $79.6 million in the same periods in the prior year. The increase in operating income in both the three and six-month periods was primarily due to the increase in segment profit in the IDS segment as a result of organic sales growth.

OPERATING INCOME TO NET INCOME

(Dollars in thousands)

Three months ended January 31, 2022 % Sales 2021 % Sales Six months ended January 31, 2022 % Sales 2021 % Sales
Operating income $42,872 13.5% $37,412 14.1% $87,207 13.6% $79,600 14.7%
Other (expense) income:
Investment and other (expense) income (578) (0.2)% 2,036 0.8% (35) —% 2,191 0.4%
Interest expense (252) (0.1)% (51) —% (434) (0.1)% (157) —%
Income before income tax and losses of unconsolidated affiliate 42,042 13.2% 39,397 14.8% 86,738 13.6% 81,634 15.0%
Income tax expense 8,227 2.6% 8,206 3.1% 17,877 2.8% 16,788 3.1%
Income before losses of unconsolidated affiliate 33,815 10.6% 31,191 11.7% 68,861 10.8% 64,846 11.9%
Equity in losses of unconsolidated affiliate — —% (331) (0.1)% — —% (505) (0.1)%
Net income $33,815 10.6% $30,860 11.6% $68,861 10.8% $64,341 11.8%

Investment and other (expense) income was a net expense of $0.6 million and investment and other (expense) income was a net income of $2.0 million for the three months ended January 31, 2022 and 2021, respectively. Investment and other (expense) income was a net expense of $0.0 million and a net income of $2.2 million for the six months ended January 31, 2022 and 2021, respectively. The decrease in the three-month and six-month period was primarily due to a decrease in the market value of securities held in deferred compensation plans.

Interest expense increased to $0.3 million and $0.4 million for the three and six months ended January 31, 2022, respectively, compared to $0.1 million and $0.2 million in the same periods in the prior year. The increase in interest expense for both the three and six-month periods was due to increased borrowing on our credit facility compared to the same period in the prior year.

The Company's income tax rate was 19.6% and 20.8% for the three months ended January 31, 2022 and 2021, respectively, and the income tax rate was 20.6% for both of the six months ended January 31, 2022 and 2021. Refer to Note L, "Income Taxes" for additional information on the Company's income tax rates.

Equity in losses of unconsolidated affiliate of $0.3 million and $0.5 million for the three and six months ended January 31, 2021, respectively, represented the Company's proportionate share of the loss in its equity interest in React Mobile, Inc., an employee safety software and hardware company based in the United States. In the fourth quarter of fiscal 2021, the Company recorded an other-than-temporary impairment charge for the Company's remaining equity interest in React Mobile, Inc.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other (expense) income, income tax expense, equity in losses of unconsolidated affiliate, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three and six months ended January 31, 2022 and 2021:

SALES GROWTH INFORMATION ID Solutions Three months ended January 31, 2022 2021 Six months ended January 31, 2022 2021
Organic 16.0% (6.9)% 14.6% (7.6)%
Acquisitions 11.8% —% 11.7% —%
Currency (1.7)% 1.5% (0.5)% 1.0%
Total 26.1% (5.4)% 25.8% (6.6)%
Workplace Safety
Organic 5.2% (4.8)% (2.0)% 0.4%
Currency (3.2)% 5.2% (1.1)% 4.8%
Total 2.0% 0.4% (3.1)% 5.2%
Total Company
Organic 13.1% (6.3)% 10.0% (5.6)%
Acquisitions 8.6% —% 8.5% —%
Currency (2.1)% 2.4% (0.7)% 2.0%
Total 19.6% (3.9)% 17.8% (3.6)%
SEGMENT PROFIT
ID Solutions $44,129 $39,000 $92,945 $79,279
Workplace Safety 4,515 3,463 6,808 11,451
Total $48,644 $42,463 $99,753 $90,730
SEGMENT PROFIT AS A PERCENT OF NET SALES
ID Solutions 18.0% 20.1% 18.8% 20.2%
Workplace Safety 6.2% 4.8% 4.7% 7.6%
Total 15.3% 16.0% 15.6% 16.7%

ID Solutions

IDS net sales increased 26.1% to $245.0 million for the three months ended January 31, 2022, compared to $194.2 million in the same period in the prior year, which consisted of organic sales growth of 16.0%, sales growth from acquisitions of 11.8% and a decrease from foreign currency translation of 1.7%. IDS net sales increased 25.8% to $493.6 million for the six months ended January 31, 2022, compared to $392.4 million in the same period in the prior year, which consisted of organic sales growth of 14.6%, sales growth from acquisitions of 11.7% and a decrease from foreign currency translation of 0.5%. Organic sales grew in all major product lines with growth in the safety and facility identification, wire identification, product identification and healthcare identification in the six months ended January 31, 2022. Organic sales increased in the mid-teens in all three regions of the IDS business in both the three and six months ended January 31, 2022, compared to the same periods in the prior year. Organic sales grew in all major product lines and in all geographies as our businesses continue to recover from the economic slowdown caused by the COVID-19 pandemic.

Segment profit increased 13.2% to $44.1 million for the three months ended January 31, 2022, compared to $39.0 million in the same period in the prior year. Segment profit increased 17.2% to $92.9 million for the six months ended January 31, 2022, compared to $79.3 million in the same period in the prior year. As a percentage of net sales, segment profit decreased to 18.0% from 20.1% for the three-month period, and segment profit decreased to 18.8% from 20.2% for the six-month period ended January 31, 2022 compared to the same periods in the prior year. The decrease in segment profit as a percentage of net sales was primarily due to gross margin compression resulting from an increase in the cost of materials, labor and freight, as well as incremental amortization expense of $2.4 million and $4.9 million in the three and six months ended January 31, 2022, respectively, which was partially offset by pricing actions, compared to the same periods in the prior year.

Workplace Safety

WPS net sales increased 2.0% to $73.1 million for the three months ended January 31, 2022, compared to $71.6 million in the same period in the prior year, which consisted of organic sales growth of 5.2% and a decrease from foreign currency translation of 3.2%. Both digital sales and catalog channel sales increased in the mid-single digits organically in the three-month period ended January 31, 2022.

WPS net sales decreased 3.1% to $145.9 million for the six months ended January 31, 2022, compared to $150.6 million in the same period in the prior year, which consisted of an organic sales decline of 2.0% and a decrease from foreign currency translation of 1.1%. The economic effect of the COVID-19 pandemic had a significant impact on organic sales trends during the prior year. The WPS business realized strong organic sales growth through the first quarter of fiscal 2021 due to increased sales of personal protective equipment and other pandemic-related products. As a result, WPS organic sales declined year-to-date in fiscal 2022 primarily due to the decrease in demand for and sales of COVID-19 products. Both digital and catalog channel sales decreased in the low-single digits organically in the six-month period ended January 31, 2022.

Organic sales in Europe increased in the high-single digits in the three months ended January 31, 2022, compared to the same period in the prior year. Organic sales in Europe were essentially flat in the six months ended January 31, 2022, compared to the same period in prior year. Digital sales increased in the mid-single digits and catalog channel sales increased in the high-single digits in the three-month period, and both digital sales and catalog channel sales were essentially flat in the six-month period ended January 31, 2022.

Organic sales in North America were essentially flat in the three months ended January 31, 2022, compared to the same period in the prior year. Digital sales increased in the mid-single digits, and sales through the catalog channel decreased in the low-single digits in the three months ended January 31, 2022. Organic sales in North America declined in the mid-single digits in the six months ended January 31, 2022, compared to the same period in the prior year. Digital sales decreased in the mid-single digits and catalog channel sales decreased in the high-single digits in the six-month period ended January 31, 2022.

Organic sales in Australia increased in the mid-single digits in the three months ended January 31, 2022 and increased in the low-single digits in the six-month period ended January 31, 2022, compared to the same period in the prior year. Digital sales increased in the high-single digits and catalog channel sales increased in the mid-single digits in the three months ended January 31, 2022, compared to the same period in the prior year. Digital sales were essentially flat and catalog channel sales increased in the low-single digits in the six months ended January 31, 2022, compared to the same period in the prior year.

Segment profit increased 30.4% to $4.5 million from $3.5 million, and as a percentage of net sales, segment profit increased to 6.2% from 4.8% for the three months ended January 31, 2022, compared to the same period in the prior year. The increase in segment profit in the three-month period was due to the increase in sales volumes as compared to the prior year. Segment profit decreased 40.5% to $6.8 million from $11.5 million and as a percentage of net sales, segment profit decreased to 4.7% from 7.6% for the six months ended January 31, 2022, compared to the same period in the prior year. The decrease in segment profit in the six-month period was due to the decrease in sales volumes as compared to prior year as well as gross margin compression due to an increase in the cost of materials, labor and freight.

Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At January 31, 2022, approximately 93% of the Company's cash and cash equivalents were held outside the United States. The Company's organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months and beyond. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

Cash Flows

Cash and cash equivalents were $147.4 million at January 31, 2022, an increase of $0.1 million from July 31, 2021. The significant changes were as follows:

(Dollars in thousands)

Net cash flow provided by (used in): Six months ended January 31, 2022 2021
Operating activities $24,328 $98,889
Investing activities (16,381) (16,392)
Financing activities (4,505) (28,828)
Effect of exchange rate changes on cash (3,370) 6,276
Net increase in cash and cash equivalents $72 $59,945

Net cash provided by operating activities was $24.3 million for the six months ended January 31, 2022, compared to $98.9 million in the same period of the prior year. The decrease was primarily due to cash outflows for inventory purchases in order to reduce the risk of supply chain disruption. In addition, annual incentive compensation payments were higher in the current six-month period than they were the same period in the prior year.

Net cash used in investing activities was $16.4 million in both the six months ended January 31, 2022 and 2021, which consisted primarily of capital expenditures in both periods.

Net cash used in financing activities was $4.5 million in the six months ended January 31, 2022, which consisted of dividend payments of $23.2 million, share repurchases of $21.7 million, and tax withholding from stock-based awards of $5.0 million, partially offset by $45.0 million net borrowing on the credit facility. Net cash used in financing activities in the six months ended January 31, 2021 of $28.8 million primarily consisted of dividend payments of $22.8 million and share repurchases of $3.6 million.

Credit Facilities

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks. At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million.

On December 21, 2021, the Company and certain of its subsidiaries entered into an amendment to the revolving loan agreement, which amends the revolving loan agreement dated as of August 1, 2019. The amendment amends the revolving loan agreement to, among other things, (a) change the interest rate under the revolving loan agreement for borrowings (i) denominated in British Pounds from the London Inter-bank Offered Rate ("LIBOR") to a daily simple SONIA-based rate, (ii) denominated in Euro from a LIBOR-based rate to a rate based on the Euro Interbank Offered Rate and (iii) denominated in Japanese Yen from a LIBOR-based rate to a rate based on the Tokyo Interbank Offered Rate, in each of the foregoing cases subject to certain adjustments specified in the revolving loan agreement; and (b) provide mechanics relating to a transition away from U.S. dollar LIBOR (with respect to borrowings denominated in U.S. dollars) and the designated benchmarks for the other eligible currencies as benchmark interest rates and the replacement of any such benchmark by a replacement benchmark rate. The amendment to the revolving loan agreement did not have a material impact on the interest rate or related balances in the Company's consolidated financial statements.

As of January 31, 2022, the outstanding balance on the Company's revolving loan agreement was $83.0 million. The maximum amount outstanding on the credit facility during the six months ended January 31, 2022 was $93.4 million. The borrowings bear interest at 0.86% as of January 31, 2022. The Company had letters of credit outstanding under the loan agreement of $1.7 million as of January 31, 2022, and there was $115.3 million available for future borrowing, which can be increased to $315.3 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024. As such, borrowings were classified as long-term on the condensed consolidated balance sheets.

Covenant Compliance

The Company's revolving loan agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of

January 31, 2022, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the agreements, equal to 0.33 to 1.0 and the interest expense coverage ratio equal to 322.7 to 1.0.

Other Commitments

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this Quarterly Report and its other filings with the Securities and Exchange Commission. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

  • Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics
  • Decreased demand for the Company's products
  • Ability to compete effectively or to successfully execute its strategy
  • Increased cost of raw materials, labor and freight as well as raw material shortages
  • Ability to develop technologically advanced products that meet customer demands
  • Ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses
  • Difficulties in protecting websites, networks, and systems against security breaches
  • Risks associated with the loss of key employees
  • Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
  • Litigation, including product liability claims
  • Foreign currency fluctuations
  • Potential write-offs of goodwill and other intangible assets
  • Changes in tax legislation and tax rates
  • Differing interests of voting and non-voting shareholders
  • Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2021.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

Market risk

As filed, 158 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2021. There has been no material change in this information since July 31, 2021.

Controls and procedures

As filed, 1,802 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-11-01 to 2022-01-31$318.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-08-01 to 2022-01-31$639.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-11-01 to 2022-01-31$168.7mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2021-08-01 to 2022-01-31$335.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-11-01 to 2022-01-31$149.4mus-gaap:GrossProfit
Gross profit6 months2021-08-01 to 2022-01-31$304.4mus-gaap:GrossProfit
Research and development3 months2021-11-01 to 2022-01-31$14.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-08-01 to 2022-01-31$27.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-11-01 to 2022-01-31$92.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2021-08-01 to 2022-01-31$189.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-11-01 to 2022-01-31$42.9mus-gaap:OperatingIncomeLoss
Operating income6 months2021-08-01 to 2022-01-31$87.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-11-01 to 2022-01-31$252.0kus-gaap:InterestExpense
Interest expense6 months2021-08-01 to 2022-01-31$434.0kus-gaap:InterestExpense
Income tax3 months2021-11-01 to 2022-01-31$8.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2021-08-01 to 2022-01-31$17.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-11-01 to 2022-01-31$33.8mus-gaap:NetIncomeLoss
Net income6 months2021-08-01 to 2022-01-31$68.9mus-gaap:NetIncomeLoss
Diluted shares (weighted)3 months2021-11-01 to 2022-01-3152,162,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-08-01 to 2022-01-3152,299,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-08-01 to 2022-01-31$24.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-08-01 to 2022-01-31$16.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2021-08-01 to 2022-01-31$23.2mus-gaap:PaymentsOfDividends
Share repurchases6 months2021-08-01 to 2022-01-31$21.7mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-01-31$147.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-01-31$500.0mus-gaap:AssetsCurrent
Total assetsAt period end2022-01-31$1.39bnus-gaap:Assets
Current liabilitiesAt period end2022-01-31$227.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-01-31$420.5mus-gaap:Liabilities
Shareholders' equityAt period end2022-01-31$966.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000746598-22-000014. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.